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Near-Infrared Fluorescence 
Imaging Directly Visualizes 
Lymphatic Drainage Pathways and 
Connections between Superficial 
and Deep Lymphatic Systems in the 
Mouse Hindlimb
Yukari Nakajima1,2, Kimi Asano1,3, Kanae Mukai4, Tamae Urai5, Mayumi Okuwa4, Junko 
Sugama5 & Toshio Nakatani4
Since lymphedema rarely develops in the mouse hindlimb, the underlying mechanisms remain unclear. 
We herein investigated the resolution of chronic hindlimb lymphedema in mice using a Near-Infrared 
Fluorescence (NIRF) imaging system. Nineteen 7–28-week-old BALB/c male and female mice were 
injected with two dyes for lymphography and dissection. Lymphadenectomy was performed on six 
male mice to completely obstruct lymph flow in the hindlimb. Edematous changes in both hindlimbs 
were compared until 60 days after surgery. The NIRF imaging system detected three lymphatic 
collecting systems in the mouse hindlimb: superficial lateral, superficial medial, and deep medial. It 
also showed connections between the superficial and deep lymphatic systems in the inguinal region. 
Lymphadenectomy of the iliac, inguinal, and popliteal lymph nodes caused edematous changes. 
However, lymph flow in these operated areas restarted within 60 days and the severity of lymphedema 
appeared to be low. NIRF imaging showed that the deep medial system and a connection between the 
superficial and deep lymphatic systems in the inguinal region drain lymph from the hindlimb. This is the 
one reasons why lymphedema does not develop in the mouse hindlimb. The stable obstruction of lymph 
flow in these three systems is desired to develop chronic lymphedema.
The lymphatic system functions as a drainage system of fluid as well as an immune system by controlling immune 
responses. It consists of lymphatics and lymph nodes (LNs), and plays important roles in the pathogenesis of 
several diseases, such as lymphedema, cancer metastasis, and various inflammatory conditions. Secondary 
lymphedema results from direct injury to the lymphatic system after surgery or radiotherapy, and, as a conse-
quence, lymph fluid accumulates in subcutaneous tissue1. Lymphatic stasis in subcutaneous tissue causes inflam-
mation, resulting in CD4+ cell inflammation and the infiltration of mature T-helper cells, and patients with 
severe lymphedema ultimately develop fibrosis2. However, the underlying mechanisms have not yet been elu-
cidated in detail3. Treatments for lymphedema, including lymphatico-venous anastomosis (LVA)4 and vascular 
endothelial growth factor-C/D (VEGF-C/D) therapy5, have been conducted in laboratories and clinical settings. 
LVA involves microsurgery that anastomoses lymphatic vessels and veins in subcutaneous tissue. However, the 
long-term patency of LVA is limited, and appears to be due to contact between lymphatic endothelial cells (LECs) 
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and platelets. Podoplanin, which is expressed in LECs, is a ligand for the C-type lectin-like receptor (CLEC-2) of 
platelets. CLEC-2 releases bone morphogenetic protein-9 (BMP-9) when activated6. A previous study reported 
that platelets, mainly BMP-9, regulate blood/lymphatic vessel separation by inhibiting the proliferation, migra-
tion, and tube formation of LECs7. This finding proposes a reason for why the long-term patency of LVA is lim-
ited. Furthermore, VEGF-C therapy has been shown to promote the lymphatic metastasis of tumor cells3. Radical 
treatments for lymphedema and their evaluation have not yet been established. Therefore, the establishment of a 
lymphedema model is desired for the development of effective treatments for patients.
Animal models of lymphedema have been previously reported. Radiation therapy is often used to generate 
lymphedema models. However, we consider this therapy to be unsuitable for the generation of a lymphedema 
model because it is associated with immobility and high mortality8,9. A tail lymphedema model may be used 
as a limb lymphedema model to elucidate the underlying mechanisms of or evaluate therapeutic approaches 
for lymphedema because its anatomy and the surgical techniques involved are simple and reproducible10. The 
superficial and deep lymphatic systems of the tail are disrupted, a 2–3 mm portion of the skin is then circumfer-
entially excised, and the deep lymphatic system is microsurgically ligated. After surgery, tail lymphedema persists 
for three weeks without necrosis or any side effects11. However, Frueh et al.10 indicated that fluctuations in the 
duration and robustness of this lymphedema depend on the surgical technique used. Furthermore, patients with 
secondary lymphedema undergo lymphadenectomy. After lymphadenectomy, the risk of infection (lymphangitis 
and cellulitis) generally increases, while immune responses become weaker12. However, only lymphatic vessels are 
excised in a tail lymphedema model. Consequently, limb lymphedema appears to be more appropriate than tail 
lymphedema for elucidating the underlying mechanisms and evaluating therapies. Previous studies performed 
lymphadenectomy on inguinal and/or popliteal LNs in order to achieve stable lymphedema in the hindlimb9,13. 
However, hindlimb edema only occurred transiently after the excision of inguinal and/or popliteal LNs. It cur-
rently remains unclear why hindlimb lymphedema does not occur, and this may be attributed to the lack of a clear 
understanding of the lymphatic system in animals. Hence, the surgical anatomy of the lymphatic system needs to 
be investigated in more detail.
Near-infrared fluorescence (NIRF) imaging has recently been introduced to visualize lymphatic and blood 
vessels3,14. The mapping of lymphatics before lymphatico-venous anastomosis, sentinel LN mapping15, and the 
classification of lymph flow patterns16 are performed using the NIRF imaging system in clinical settings to visu-
alize lymphatics. These approaches provide real-time guidance on the location of the lymphatic system. In addi-
tion, NIRF easily detects lymphatics, which are visible to the naked eye, without dissection or special techniques. 
Therefore, NIRF imaging is beneficial for the visualization of lymphatic drainage pathways and localization of the 
lymphatic system.
The purpose of the present study was to obtain detailed information on the lymphatic system in the mouse 
hindlimb using the NIRF imaging system. A clearer understanding of the lymphatic system is important for 
achieving stable lymphedema.
Results
Detection of Lymphatic Vessels Using the NIRF Imaging System. We performed lymphography, 
dissection, and histological observations in order to identify the location at which lymph fluid in the hindlimb is 
drained. Figure 1 shows the lymphatic collecting system of the hindlimb and above the level of the hindlimb from 
lymphographic, macroscopic, and microscopic images of intact mice. Three main lymphatic collecting systems 
were identified in the hindlimbs of mice: (1) superficial lateral; (2) superficial medial; (3) deep medial. We named 
these systems based on a previous study that examined the normal anatomy of lymphatics in the dog hindlimb17. 
There is no variation in these lymphatic systems of the hindlimb between different animals of the BALB/c strain. 
All lymphatics detected in the present study were ipsilateral and without sex or age differences.
Figure 1a shows the superficial lateral system of the left hindlimb of a mouse. It started as a network on the 
foot pad and then crossed to the lateral side of the hindlimb at the level of the lower one third or middle of the calf 
(closed green arrowhead). This system passed through the popliteal LN to the sciatic LN along with blood vessels 
(open green arrowhead). It was detected by an intradermal injection of ICG into the foot pad. The injection site 
was indicated as a green arrow in Fig. 2.
Figure 1b shows the superficial medial system of the right hindlimb of a mouse. It appeared to start above the 
level of the ankle (closed yellow arrowhead). It was not possible to observe this system under the level of the ankle 
because it was detected by a subcutaneous injection of ICG into the ankle. This system passed into the thigh and 
through the inguinal LN (closed yellow arrowheads), and then ran into the axillary LN along with blood vessels 
in the abdomen (open yellow arrowheads). This system was detected by a subcutaneous injection of ICG into the 
ankle. The injection site was indicated as a yellow arrow in Fig. 2.
Figure 1c showed the deep medial system of the left side in a mouse. It started at the interior part of the hind-
limb, ran with the femoral artery into the thigh, entered the abdominal cavity (closed white arrowheads), and 
then ran into the iliac LN (open white arrowheads). This system was detected by an intradermal injection of dyes 
into the foot pad. The injection site was indicated as a gray arrow in Fig. 2. Lymph fluid drained into the abdom-
inal cavity through this system (Supplemental video 1). Another lymphatic that contributed to the deep medial 
system was detected by the NIRF imaging system during the experiment. After a subcutaneous injection of dyes 
into the ankle, this lymphatic was observed by stretching the skin to the sagittal line (closed red arrows in Fig. 1c, 
Supplemental video 2). The injection site was indicated as a yellow arrow in Fig. 2. After dissection, this lymphatic 
appeared to start at the level of the inguinal region and ran into the iliac LN with blood vessels and nerves (closed 
red arrows in Fig. 1c). Furthermore, this lymphatic was surrounded by subcutaneous tissue and easily destroyed. 
Lymph fluid from the superficial medial system drained into the deep medial system through this lymphatic 
(Supplemental video 2). This lymphatic appeared to start from the inguinal LN or branched from the superficial 
medial system. However, difficulties were associated with precisely identifying its origin in the present study.
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The NIRF imaging system detected two lymphatics that have not been reported in previous studies, as shown 
in Fig. 1d (open blue arrowheads) and 1e (open purple arrowheads). The first lymphatic, which started at the 
lower abdomen and ran into the axillary LN (open blue arrowheads), was detected by an ICG injection into 
the lower abdomen (blue arrow on the left figure in Fig. 2). Mice were found to have two large lymphatics in 
the abdomen. These lymphatics were also observed histologically (bottom images in Fig. 1d). Second lymphat-
ics, which started from the lower back and ran into the axillary LN (open purple arrowheads in Fig. 1e), were 
detected by an ICG injection into the lower back (purple arrow on the right figure in Fig. 2). This lymphatic was 
also observed histologically (right bottom image in Fig. 1e). Figure 2 shows a schematic drawing of the lymphatic 
Figure 1. Lymphatic systems detected by visual images, NIRF, and photomicrographs. Visual images of mice 
on (a) to (e) revealed each location of right NIRF images. Green large boxes showed the high magnification of 
each site in green small boxes. (a) The superficial lateral system passed the calf muscle (closed green arrowhead) 
through the popliteal lymph node (LN) and onto the sciatic LN (open green arrowhead), left hindlimb, injection 
site; green arrow in Fig. 2. (b) The superficial medial system passed into the thigh and through the inguinal 
LN (closed yellow arrowheads), and then ran into the axillary LN (open yellow arrowheads), right hindlimb. 
Injection site; yellow arrow in Fig. 2, dashed white line; the level of the ankle, Scale bar; 1 cm. (c) Upper images; 
the deep medial system passed into the thigh and entered the abdominal cavity (closed white arrowheads), then 
ran into the iliac LN (open white arrowheads), left hindlimb. The right image was obtained after dissection of 
the abdominal cavity. Injection site; gray arrow in Fig. 2. Bottom images; another lymphatic that contributes 
to the deep medial system (closed red arrowheads) was detected between the inguinal and iliac LNs by the 
injection of dyes at the site indicated by the yellow arrow in Fig. 2. (d) A newly detected lymphatic from the 
lower abdomen to the axillary LN (open blue arrowhead), left lateral position. Injection site; blue arrow on the 
left figure in Fig. 2. Hematoxylin and eosin (H&E)-stained images; cross-sectional images at the level of the 
orange line in the upper right image. Scale bars; upper right 1 cm, bottom left 50 µm, bottom right 100 µm. (e) 
Lymphatics arising from the lower back and running to the superficial axillary LN (open purple arrowheads), 
left lateral position. A H&E image was obtained at the level of the orange line in the left bottom image. Injection 
site; purple arrow on the right fig. in Fig. 2. Scale bar; 50 µm. *AX; axillary LN, *IN; inguinal LN, *IL; iliac LN, 
*PO; popliteal LN, *SC; sciatic LN, A; artery, V; vein, int; intestine, lh; left hindlimb.
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system detected by NIRF in the present study. Based on this lymphatic system, operated areas were selected to 
obstruct lymph fluid in the hindlimb.
Lymphedema Formation and the Impact of Lymphadenectomy in the Hindlimb. In order to 
obstruct lymph fluid in the hindlimb, the inguinal, popliteal, and iliac LNs were excised by surgery because these 
LNs are located on the three lymphatic systems in the hindlimb. The operated side showed edematous changes 60 
days after lymphadenectomy. Macroscopically, remaining Evans blue dye, which was injected on the operated day, 
was clearly observed in the operated side (Fig. 3a), although the control side received the same dose of dye on the 
same day. After the injection of ICG into the ankle on day 58, the rate of luminance was calculated on day 60. It 
was higher on the operated side than on the control side (Fig. 3b). Furthermore, the hindlimb circumference and 
volume were higher on the operated side than on the control side on day 60 (Fig. 3c,d).
Lymphography was performed on day 60 on both hindlimbs after the ICG injection in order to clarify whether 
lymph flow in the operated areas was obstructed by surgery. The control side in each animal showed normal 
lymph flow. However, in the operated area from which the popliteal LN was excised, lymph flow was obstructed 
in approximately 85% of mice (left image in Fig. 3e). Lymph fluid in the superficial lateral system drained into 
the sciatic LN in one mouse after excision of the popliteal LN. In operated areas from which the inguinal LN was 
excised, lymph flow was obstructed in approximately 16% of mice. Tortuous lymph flow was detected around the 
operated area. Mice showed well-developed detours toward lymphatics of the abdomen after surgery. The detours 
around this operated area connected two lymphatics in the abdomen in two mice (central image in Fig. 3e) and 
one lymphatic in the abdomen in three mice. Lymph fluid through the superficial medial system passed these 
detours and was then drained into the deep or superficial axillary LN. In operated areas from which the iliac LN 
was excised, lymph flow passed into the deep medial system, accumulated in the operated area, and then entered 
into the thoracic duct (right image in Fig. 3e). Detours were not observed around this operated area. Lymph flow 
in this area restarted in all mice.
Histological findings on the operated side were compared to those on the control side in order to identify the 
impact of lymphadenectomy. The area of capillary lymphatics detected by the anti-LYVE-1 antibody was greater 
on the operated side than on the control side (Fig. 4a,b). The number of CD4+ cells was two-fold higher on the 
Figure 2. Schematic drawing of the lymphatic system related to the drainage of lymph fluid in the hindlimb of 
mice. This figure was based on results obtained from lymphography and the dissection of mice. Black circles; 
lymph nodes (LNs), dashed black lines; lymphatics in the intra-abdomen or intrathoracic area, black solid lines; 
lymphatics in subcutaneous tissue or muscle on the upper limb or buttock, green solid lines; the superficial 
lateral system corresponding to open and closed green arrowheads in Fig. 1a, yellow solid lines; the superficial 
medial system corresponding to open and closed yellow arrowheads in Fig. 1b, gray solid lines; the deep medial 
system corresponding to open and closed white arrowheads in Fig. 1c, red solid line; lymphatics that started 
at the level of the inguinal region and ran into the iliac LN corresponding to closed red arrowheads in Fig. 1c, 
blue solid lines; lymphatics that started at the lower abdomen and ran into the axillary LN corresponding to 
open blue arrowheads in Fig. 1d, purple solid lines; lymphatics that started from the lower back and ran into the 
axillary LN corresponding to open purple arrowheads in Fig. 1e. Open green arrow; the injection site of dyes 
that visualized the superficial lateral system, open yellow arrow; the injection site of the dyes that visualized the 
superficial medial system and lymphatics revealed by red solid lines, open gray arrow; the injection site of the 
dyes that visualized the deep medial system. The open gray arrow is the same site as the open green arrow. Left 
figure; supine position, right figure; prone position. IN; inguinal LN, AX; axillary LN, IL; iliac LN, PO; popliteal 
LN, SC; sciatic LN.
www.nature.com/scientificreports/
5SCIeNTIFIC RePORtS |  (2018) 8:7078  | DOI:10.1038/s41598-018-25383-y
operated side than on the control side. These results revealed that local inflammation occurred after lymphad-
enectomy (Fig. 4c,d). The ratios of collagen I in the dermis and subcutaneous tissue were calculated in order to 
evaluate the degree of fibrosis. No significant differences were observed between the two sides (Fig. 4e to h).
Discussion
In the present study, NIRF detected three lymphatic collecting systems in the mouse hindlimb. The superficial lat-
eral and superficial medial systems have already been reported18–20. These lymphatic systems were also observed 
in the rat13. Previous studies excised the popliteal or/and inguinal LNs in an attempt to obstruct these systems and 
develop hindlimb lymphedema. However, the resolution of lymphedema in the hindlimb gradually occurred after 
several weeks by surgery only9,13. The present study showed that the deep medial system and lymphatics between 
the inguinal and iliac LNs drain lymph fluid in the hindlimb to the iliac LN, similar to the superficial lateral or 
superficial medial system. The present results strongly suggest that this is the one of the reasons why hindlimb 
lymphedema does not develop following surgery. Hence, we need to obstruct not only the popliteal and inguinal 
LNs, but also the iliac LN in order to develop hindlimb lymphedema. In the present study, lymphatics between the 
inguinal and iliac LNs were detected in all mice. Lymphography of these lymphatics showed that these lymphatics 
drain lymph fluid from the superficial to deep lymphatic systems, and, thus, are a connection between these sys-
tems. This connection has not been reported in previous studies that examined animals. In humans, no connec-
tions between the superficial and deep lymphatic vessels were observed in the inguinal region21–23. Connections 
Figure 3. Macroscopic observations after lymphadenectomy. (a) Representative images of mice subjected 
to lymphadenectomy, right hindlimb; the operated side, left hindlimb; the control side. (b) The ratio of 
luminance on day 60. A 2-μl injection of indocyanine green (ICG) was performed on both hindlimbs on day 
58. (c) Changes in hindlimb circumference until day 60. (d) Changes in hindlimb volume until day 60. (e) 
Representative images of lymphography obtained from operated areas on day 60 after lymphadenectomy. Left 
image; operated areas from which popliteal lymph nodes (LNs) were excised after a 2- to 10-μl injection of 
ICG at both food pads, center image; operated areas from which inguinal LNs were excised after a 2- to 10-μl 
injection of ICG at both ankles, right image; operated area from which iliac LNs were excised after a 2- to 
10-μl injection of ICG at both food pads. In some mice, lymph flow connected two lymphatics in the abdomen 
(yellow and blue arrowheads) after passing the hindlimb. Red crosses; operated area, IN; inguinal LN. N = 6 in 
b, c, d and e. *P < 0.05 and **P < 0.01 versus the control (paired t-test).
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between the superficial and deep lymphatic systems have only been reported above the elbow along the basilic 
vein24 and popliteal region in cadavers23. The connections between the superficial and deep lymphatic systems 
differ between species. Therefore, this result is very valuable for understanding not only the lymphatic system, but 
also differences in lymphatic systems between species.
We performed lymphadenectomy in order to interrupt lymph drainage in the hindlimb. The operated side 
showed an increased hindlimb circumference, volume and stasis of lymph fluid, inflammation, and lymphatic 
area. These edematous changes have been reported previously2,25,26. The circumference of the hindlimb and the 
volume and stasis of lymph fluid were measured in order to evaluate the extent of lymph edema20,27,28. These 
parameters all increased in edematous tissue. In the histology of edematous tissue, lymphatic stasis causes CD4+ 
cell accumulation in subcutaneous tissue and leads to inflammation2,29. Furthermore, the average cross-sectional 
areas of lymphatics significantly increase as a result of lymphedema responses26. Therefore, lymphadenectomy of 
the popliteal, inguinal, and iliac LNs appears to produce stable lymphedema in the hindlimb. However, in clinical 
settings, patients with severe lymphedema ultimately develop fibrosis30. In the present study, lymphadenectomy 
of the popliteal, inguinal, and iliac LNs did not cause fibrosis. We attributed this result to lymph flow in areas in 
which LNs were excised restarting within 60 days of surgery. Lymph fluid was not completely obstructed in the 
present study. Hadrian et al.31 reported that rodent models showed high endogenous lymphatic regeneration; 
therefore, stable lymphedema rarely developed. Hindlimb lymphedema in mice may not be produced by surgery 
only. We consider the stable obstruction of lymph fluid in the three lymphatic collecting systems achieved in the 
present study using other approaches to result in the development of chronic lymphedema in mice. Further stud-
ies are needed in order to induce the stable obstruction of these lymphatic systems.
Advances have recently been achieved in the development of measuring devices. However, current knowledge 
on the anatomy of the lymphatic system in mice is largely based on studies conducted before 2000. In the pres-
ent study, we used NIRF to identify lymphatic systems, and it successfully detected novel lymphatics. A better 
understanding of the anatomy of the lymphatic system using recently developed devices will lead to more effective 
treatments, care, and the prevention of iatrogenic lymphedema by surgery in patients with lymphedema.
Study limitations. Lymph draining through interstitial flow was not evaluated in the present study. 
Although lymph in the hindlimb was partly drained by interstitial flow, we were unable to establish how much 
lymph flowed interstitially and what its impact was. This study was conducted using BALB/cCrSlc mice. There 
is very limited information on the anatomy of lymphatic systems in the hindlimb in other strains of animals. 
Therefore, the lymphatic system needs to be investigated in lymphedema models of other strains of animals. 
Since NIRF does not have the ability to detect the deep lymphatic system in the abdominal cavity, when the deep 
lymphatic system is being examined, dissection is needed to confirm lymph flow.
Conclusions
NIRF detected three lymphatic collecting systems in the mouse hindlimb: the superficial lateral, superficial 
medial, and deep medial collecting lymphatic systems. Lymphatics between the inguinal and iliac LNs represent 
a connection between the superficial and deep medial lymphatic systems in mice. Lymphadenectomy of the 
popliteal, inguinal, and iliac LNs resulted in stable lymphedema in the hindlimb; however, its severity appeared 
to be low. Further studies are needed in order to completely obstruct lymphatic systems for the development of a 
severe lymphedema model.
Figure 4. Histological evaluation of the hindlimb after lymphadenectomy on day 60. (a) The area of capillary 
lymphatics in 1 mm2 of the dermis. (b) Representative photomicrographs of LYVE-1 immunohistochemical 
staining in the operated side (left) and control side (right). (c) The number of CD4+ cells in the dermis and 
subcutaneous tissue in 1 mm2. (d) Representative photomicrographs of CD4 immunohistochemical staining 
in the operated side (left) and control side (right). (e) The ratio of collagen I in the dermis. (f) Representative 
photomicrographs of collagen I immunohistochemical staining in the operated side (left) and control side 
(right). (g) The ratio of collagen I in subcutaneous tissue. (h) Representative photomicrographs of collagen I 
immunohistochemical staining in the operated side (left) and control side (right). Black arrows; lymphatics (b), 
CD4+ cells (d). N = 5 in a, c, e, and g. **P < 0.01 versus the control (paired t-test).
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Methods
All procedures involving animals were reviewed and approved by the Committee on Animal Experimentation of 
Kanazawa University (AP-163811). The methods were performed in accordance with the approved guidelines.
Mice. Twenty-five BALB/cCrSlc male and female mice (Sankyo Lab Service Corporation, Inc., Toyama, Japan) 
weighing 19.7–30.7 g were used at 7 to 28 weeks of age. They were caged individually in an air-conditioned room 
at a temperature of 25.0 ± 2.0 °C, and the lights were kept on between 08:15 and 20:15 hours. Water and pelleted 
food were given freely.
Nineteen male and female mice aged 7 to 28 weeks were subjected to lymphography and dissection in order to 
identify lymphatics in the hindlimb. Six male mice aged 12 weeks were subjected to lymphadenectomy. The detail 
protocol of surgery was shown below.
Dissection of Mice. The injection dye was composed of a mixed solution of 3%w/v Evans blue dye 
(Sigma-Aldrich Japan, Tokyo, Japan) and indocyanine green (ICG; Daiichi Sankyo, Tokyo, Japan) at a concen-
tration of 2.5 mg/ml. The ratio of Evans blue dye to ICG was two to one. Mice were anesthetized with 2% isoflu-
rane, and 15–30 μl of the injection dye was intradermally or subcutaneously administered at different areas (the 
footpad, ankle, back, or lower abdomen) to visualize lymphatics and LNs. Fifteen to 30 minutes after the injection 
under awakening, mice were euthanized via an intraperitoneal (IP) injection of a large dose of pentobarbital 
sodium (0.5 mg/g weight), and dissected to locate the lymphatics and LNs of interest.
Lymphography by NIRF Imaging. Lymphatics were visualized using the NIRF imaging system (Pde-neo; 
Hamamatsu Photonics K.K., Shizuoka, Japan) after anesthetization with 1.5% isoflurane. Pde-neo emitted light 
at 760 nm and detected light at wavelengths greater than 820 nm, and, thus, detected ICG flow because ICG has 
an excitation wavelength of 805 nm and emission wavelength of 840 nm18,32. After an injection of 2 to 10 μl ICG, 
we massaged the injection site using absorbent cotton wool to promote ICG absorbance. Fluorescent images of 
lymph flow were obtained by Pde–neo.
Surgical Procedures for Lymphadenectomy. Mice were anesthetized with 2% isoflurane. Iliac LNs were 
identified after the intradermally injection of 15 μl of 3%w/v Evans blue dye into the food pad. After 10 minutes, 
flunixin (Banamine®, 5 mg/kg weight; AdooQ BioScience, CA) and enrofloxacin (8.5 mg/kg weight; Wako Pure 
Chemical Industries, Ltd., Osaka, Japan) were injected subcutaneously as analgesics and antibiotics. A 1.0-cm 
incision into the abdominal muscle was made, the small intestine was pulled out, and the right iliac LN was 
excised using scissors. The small intestine was kept wet by applying saline at a temperature of 37 °C during sur-
gery. After the excision of the iliac LN, 1 ml of sterile saline (0.9%) was injected intraperitoneally to support fluid 
homeostasis. Surgical wounds were secured using 6–0 nylon simple interrupted sutures, and surgical sites were 
then bonded together and dressed with gauze. Postoperative care was performed for these mice based on a previ-
ous study33. Flunixin (5 mg/kg weight) was administered subcutaneously twice per day (every 12 hours) for 7 days 
as analgesics, and 300 μl glucose (5%) and 300 μl saline (0.9%) were injected subcutaneously twice per day for 7 
days as fluid therapy. Mice had free access to glucose (15%) offered in a second drinking bottle. One week after 
surgery, the inguinal and popliteal LNs were identified by a injection of 15 μl of 3% Evans blue dye solution into 
the ankle and food pad, delivered using a micro syringe with a 27 G needle. The surgical procedures for excising 
the inguinal LN were described in our previous study32. The right hindlimb was the operated side, while the left 
hindlimb was the control side. The control side did not undergo a sham operation (untreated). In our preliminary 
examination, sham operation using two mice did not occur edematous changes and these operation areas did 
not affect for histological evaluation (data not shown). Therefore, skin characteristics after the operation were 
compared with normal skin characteristics.
Lymphedema Assessment. The circumferences of both hindlimbs were measured using adhesive tape 
(TransporeTM surgical tape, Tokyo, Japan) to assess the extent of postsurgical edema. The degree of lymphedema 
was also quantified by measuring hindlimb volumes using a water displacement volumetry method as described 
previously27. The ratio of luminance (%) = total pixels of fluorescent areas on the lateral, front, and back sides in 
the hindlimb/total pixels of hindlimb areas on the lateral, front, and back sides. The ratio of luminance on day 60 
was calculated to quantify the degree of lymphatic stasis after an injection of 2 μl ICG at the ankle on both hind-
limbs on day 58. We did not massage the injection site in this evaluation.
Specimens of the hindlimb were stained immunohistochemically. The procedure used was described in detail 
below. The area of capillary lymphatics in the dermis (µm2/mm2) = the total area of capillary lymphatics in the 
dermis/mm2 dermis. The number of CD4+ cells (number/mm2) = the number of CD4+ cells/mm2 dermis and 
subcutaneous area. The ratio of collagen I (%) = pixels of collagen fibers/pixels of the dermis or subcutaneous 
area. These parameters were calculated by Adobe Photoshop Element 11.0 (Adobe System, Inc., Tokyo, Japan). 
The operated side was compared with the control side for all parameters.
Immunohistochemistry. After dissection, specimens of skin on the lower external hindlimb were har-
vested, stapled onto transparent plastic sheets to prevent excessive contractions, and fixed in 4% paraformalde-
hyde in 0.1 mol/L phosphate buffer (pH 7.4) overnight. Specimens were then placed in 10% sucrose in PBS for 
2 hours, 20% sucrose in PBS overnight, and 30% sucrose in PBS overnight before embedding OCT compound 
(Sakura® Finetek, Tokyo, Japan). Frozen tissue was stored at −80 °C until used. Ten-micrometer-thick sections 
were mounted on MAS-coated glass slides (Matsunami Glass Ind., Ltd., Osaka, Japan) for hematoxylin and eosin 
(H&E) or immunostaining. Sections for immunostaining were washed with PBS/0.03% Tween-20 (PBST), incu-
bated with blocking solution (X0909, Dako, CA) and 0.3% hydrogen peroxide, and then incubated with primary 
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antibodies diluted in PBST at room temperature (RT) for 2 hours. Sections were washed three times using PBST. 
They were then incubated with the secondary antibodies linked with HRP at RT for 1 hour. The primary antibod-
ies used in the present study were an anti-LYVE-1 antibody (ab14917, Abcam), anti-CD-4 antibody (ab25475, 
Abcam), and anti-collagen I antibody (ab34710, Abcam).
Statistical Analyses. Data were compared using the paired t-test with JMP 8.0.1 (SAS, USA). Results were 
expressed as the mean ± SD. A P-value of less than 0.05 was used as the criterion to indicate significance.
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